Champions Oncology Inc Sustainability Reports
Champions Oncology, Inc. develops advanced technology solutions and data-driven research strategies to personalize the development and use of oncology drugs. The company utilizes its proprietary TumorGraft technology platform, featuring patient-derived xenograft models, to offer specialized pharmacology and biomarker testing services.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
LEI: 549300O8WKLP8QEG5U47
FIGI: BBG001S5YHT9
7 reports from 2020 to 2026
